secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001380106-26-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems pre-announces record Q4 rev $11.3M (+37% YoY); FY rev $33.6M (+20%)
--------------------------------------------------------------------------------

- Q4 2025 total revenue expected ~$11.3M, up ~37% YoY; record multi-system order from Top 20 biopharma customer.
- Full year 2025 revenue expected ~$33.6M, up ~20% YoY; recurring revenue $17.8M (+15%).
- Q4 placed 16 new Growth Direct systems, validated 3 customer systems; full year placed 28 and validated 18.
- Cumulative installed base: 190 systems globally, 155 validated.
- Company to announce complete FY2025 results and 2026 outlook later in Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/0001380106-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000007/rpid-20260113.htm
  HTML page:      https://secwatch.observer/filing/0001380106-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer